A review of matched-sample benchmarking studies finds standard RNA-seq recovers only 3–5% of TCR clonotypes identified by ...

A new deconvolution framework called ESMF uses single-cell reference data, negative binomial noise modeling and ...

Researchers identified RNA-associated amyloid fibrils in human seminal fluid and demonstrated that synthetic PAP fibrils ...

Rotow, MD, explains how RNA-based next-generation sequencing (NGS) fits into testing for newly diagnosed advanced nonsquamous non-small cell lung cancer (NSCLC) in a discussion moderated by Matthew A.

Tempus xR RNA sequencing assay receives EU IVDR Class C certification, supporting continued clinical and biopharma access in ...

Tempus AI, Inc. Enters Into Multi-Year Agreement With Bristol Myers Squibb To License Multimodal Oncology Data CI Oct. 23 Pathos AI Announces Strategic Collaborations With Bristol Myers Squibb And ...

Tempus AI, Inc. (NASDAQ: TEM) today announced that its xR assay has received certification under the European Union's In Vitro Diagnostic Regulation (IVDR) as a Class C in vitro diagnostic device. The ...

Precision-cut lung slices allow researchers to study living human lung tissue outside the body, preserving the different cell ...

CHICAGO--Tempus AI, Inc. (NASDAQ: TEM) today announced that its xR assay has received certification under the European ...

According to MarketsandMarkets™, the Next-generation Sequencing Services Market is projected to reach USD 9.37 billion by ...

New RNA extraction techniques overcome barriers to help scientists better evaluate treatments for diseases such as pulmonary ...